Literature DB >> 8103009

Gallstones during octreotide therapy.

R H Dowling1, S H Hussaini, G M Murphy, J A Wass.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103009     DOI: 10.1159/000201088

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  5 in total

1.  Hepatolithiasis (intrahepatic stone) during octreotide therapy for acromegaly: a case report.

Authors:  M T Sheehan; T B Nippoldt
Journal:  Pituitary       Date:  2000-12       Impact factor: 4.107

2.  Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Authors:  P Ruszniewski; M Ducreux; J A Chayvialle; J Blumberg; D Cloarec; H Michel; J M Raymond; J L Dupas; H Gouerou; R Jian; E Genestin; P Bernades; P Rougier
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

3.  Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.

Authors:  T Gilat; A Leikin-Frenkel; L Goldiner; H Laufer; Z Halpern; F M Konikoff
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

4.  How to manage a high-output stoma.

Authors:  Jeremy M D Nightingale
Journal:  Frontline Gastroenterol       Date:  2021-03-22

5.  Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.

Authors:  M F Stolk; K J van Erpecum; H P Koppeschaar; M Samsom; A J Smout; L M Akkermans; T L Peeters; G P vanBerge-Henegouwen
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.